| APHIS Section 18 Exemption for use of Sodium Hydroxide |
|
|
|
|
|
|
|
| Annual Usage Report |
|
|
|
|
|
|
|
|
Question |
Response |
|
|
|
|
|
|
|
| 1 |
Report Period |
09/01/2019-08/31/2020 |
|
|
|
|
|
|
|
| 2 |
Facility Name |
USDA Veterinary Services- Field |
|
|
|
|
|
|
|
| 3 |
Facility Address |
Various |
|
|
|
|
|
|
|
| 4 |
Facility Physical Location, if different from address |
|
|
|
|
|
|
|
|
| 5 |
Facility Contact Name |
Dr. Jennifer Siembieda |
|
|
|
|
|
|
|
| 6 |
Facility Contact Phone Number |
970-278-7893 |
|
|
|
|
|
|
|
| 7 |
Facility Contact Email |
[email protected] |
|
|
|
|
|
|
|
| 8 |
Product |
Sodium Hydroxide |
|
|
|
Breithart vet center |
|
CSU |
|
| 9 |
Formulation used (powder/flakes or liquid) |
pure powder and liquid 10N |
Sodium Hydroxide (10N) Liquid (32% solution) |
|
|
liquid |
|
powder |
|
| 10 |
Number of treatments |
135 |
25 |
|
|
10 |
|
varies-used in sharps containers (not reported so back calculated = 100) |
|
| 11 |
Amount of product used per treatment (grams) density assumed to be 1.32 g/mL - should be concentration (g/mL) |
99.39 |
1/5 Gallon (1 Part 10N Sodium Hydroxide + 4 Part Chemical Waste) |
319.79 |
grams |
100 ml |
42.24 |
50 grams |
|
| 12 |
Total amount used (in grams) by facility during reporting period (line 10 x line 11) |
13,417.19 |
~5 Gallons |
7,994.79 |
grams |
1000 mL |
422.4 |
5 kg |
5000 |
| 13 |
Were there any adverse reactions* reported as a result of the use of this product during the last 12 months (if yes, please describe). |
|
18,927.06 |
mL |
|
|
|
|
|
| 14 |
Was there any visible contaminated material remaining after the decontamination protocol? |
|
1 gallon = 3785 mL |
|
|
|
|
|
|
| 15 |
If an APHIS facility or an APHIS-approved partner facility, was the application of the product monitored in compliance with the facility's standard operating procedure (if a private facility, enter "NA")? |
|
|
|
|
multiply solution by density and then concentration -> 1000mL x 1.32 g/mL x 32% w/v = 422.4 grams of NaOH |
| 16 |
If a private agriculture facility, was the application of the product during the decontamination protocol reviewed with the facility owner prior to the protocol? Did APHIS follow-up to ensure that the recommended standard operating procedure was followed (if not a private facility, enter "NA")? |
|
|
|
|
|
|
|
|
| 17 |
If the answer to question 15 or 16 was "No" list the corrective actions taken. |
|
|
|
|
|
|
|
|
| 18 |
Does your facility practice any additional risk mitigations not mentioned in the application? |
|
|
|
|
|
|
|
|
| 19 |
Additional information facility wants to report (if none, please enter "NA")? |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| * Include all adverse reactions observed in staff, livestock, wildlife and the environment. |
|
|
|
|
|
|
|